Cardiovascular and Metabolic Outcomes of Hormone Replacement Therapy in Women Aged 65 Years and Older: A Systematic Review of Randomized Clinical Trials
Clin Pharmacol. 2026 Sep 9;18:581397. doi: 10.2147/CPAA.S581397. eCollection 2026.ABSTRACTBACKGROUND: The cardiovascular, kidney, and metabolic effects of hormone replacement therapy (HRT) in postmenopausal women, particularly those who initiate treatment after age 65, remain incompletely characteri

